<DOC>
	<DOCNO>NCT02274428</DOCNO>
	<brief_summary>Phase 1 clinical trial safety dose determination Pneumostem ( human umbilical cord blood derive mesenchymal stem cell ) premature infant intraventricular hemorrhage ( IVH , grade 3-4 )</brief_summary>
	<brief_title>Phase 1 Clinical Trial PNEUMOSTEMÂ® Treatment Premature Infants With Intraventricular Hemorrhage</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Cerebral Hemorrhage</mesh_term>
	<criteria>2334w IVH grade 34 , confirm brain ultrasonogram within 7 day IVH diagnosis severe congenital anomaly intrauterine intracranial bleed intracranial infection severe congenital infection active uncontrolled infection , CRP &gt; 10mg/dl Platelet count &lt; 50,000/ml severe metabolic acidosis ( PH &lt; 7.1 , BE &lt; 20 )</criteria>
	<gender>All</gender>
	<minimum_age>23 Weeks</minimum_age>
	<maximum_age>34 Weeks</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>intraventricular hemorrhage</keyword>
</DOC>